Venetoclax: Potential Use in Multiple Myeloma

Venetoclax: Potential Use in Multiple Myeloma

Venetoclax: Potential Use in Multiple Myeloma

A. Keith Stewart, MB, ChB; Sagar Lonial, MD, FACP; Thomas Martin, MD; Edward A. Stadtmauer, MD; Amrita Krishnan, MD, FACP; and Ajai Chari, MD, consider venetoclax’s role in the treatment of multiple myeloma and whether its potential is limited to patients with t(11;14) as a biomarker.

Leave a Reply

Your email address will not be published. Required fields are marked *